ID

15180

Description

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Keywords

Versions (1)
  1. 5/21/16 5/21/16 -
Uploaded on

May 21, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC-ND 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441

English

Protocol IB AIEOP-BFM ALL 2009 NCT01117441

1 forms  
Patient Information
Description

Patient Information

Alias
UMLS CUI-1
C1955348
Stud.-Nr. (Pat.-ID)
Description

Patient ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Patient date of birth
Description

Patient birthday

Data type

date

Alias
UMLS CUI [1]
C0421451
Body weight
Description

Weight

Data type

float

Measurement units
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Body height
Description

Height

Data type

float

Measurement units
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Body surface
Description

Body surface

Data type

float

Measurement units
  • mˆ2
Alias
UMLS CUI [1]
C0005902
mˆ2
Chemotherapy Regimen
Description

Chemotherapy Regimen

Alias
UMLS CUI-1
C0392920
Cyclophosphamide administration form p.i. (1h) (+ MESNA)
Description

CPM: administration form

Data type

boolean

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C1827465
Cyclophosphamide 1000 mg/mˆ2/ED
Description

CPM: dosage

Data type

float

Measurement units
  • mg
Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C0178602
mg
Cyclophosphamide Date of administration
Description

CPM: date of administration

Data type

date

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C2584899
ARA-C administration form i.v.
Description

ARA-C: administration form

Data type

boolean

Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C0013153
ARA-C dosage 75 mg/mˆ2/ED
Description

ARA-C: dosage

Data type

float

Measurement units
  • mg
Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C0178602
mg
ARA-C Date of administration
Description

ARA-C: date of administration

Data type

date

Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C2584899
Thioguanine administration form p.o. (14d)
Description

TG: administration form

Data type

boolean

Alias
UMLS CUI [1,1]
C0039902
UMLS CUI [1,2]
C0013153
Thioguanine dosage 60 mg/mˆ2/d
Description

TG: dosage

Data type

float

Measurement units
  • mg
Alias
UMLS CUI [1,1]
C0039902
UMLS CUI [1,2]
C0178602
mg
Thioguanine Start date of therapy
Description

TG: start date

Data type

date

Alias
UMLS CUI [1,1]
C0039902
UMLS CUI [1,2]
C0808070
Thioguanine End date of therapy
Description

TG: end date

Data type

date

Alias
UMLS CUI [1]
C0806020
MTX administration form i.th
Description

MTX: administration form

Data type

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0677897
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
Description

MTX: dosage

Data type

float

Measurement units
  • mg
Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
mg
MTX Date of administration (while MTX infusion)
Description

MTX: date of administration

Data type

date

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C2584899
Hospitalization
Description

Hospitalization

Alias
UMLS CUI-1
C0019993
If member of randomization group R2, specify: Number of Nights in Hospital (Day 36 until start of maintenance treatment)
Description

Hospital nights

Data type

float

Measurement units
  • nights
Alias
UMLS CUI [1]
C0420496
nights
Identification and Signature
Description

Identification and Signature

Alias
UMLS CUI-1
C0205396
UMLS CUI-3
C1519316
Date and signature of the doctor who calculated and created chemotherapy regimen
Description

Chemotherapy creator: signature

Data type

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1707531
UMLS CUI [2]
C1519316
Date and signature of the person who administered chemotherapy
Description

Chemotherapy administration: signature

Data type

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1533734
UMLS CUI [2]
C1519316
Back to the top of the page

Similar models

Protocol IB AIEOP-BFM ALL 2009 NCT01117441

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient ID
Item
Stud.-Nr. (Pat.-ID)
text
C2348585 (UMLS CUI [1])
Patient birthday
Item
Patient date of birth
date
C0421451 (UMLS CUI [1])
Weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Height
Item
Body height
float
C0005890 (UMLS CUI [1])
Body surface
Item
Body surface
float
C0005902 (UMLS CUI [1])
Item Group
Chemotherapy Regimen
C0392920 (UMLS CUI-1)
CPM: administration form
Item
Cyclophosphamide administration form p.i. (1h) (+ MESNA)
boolean
C0010583 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
CPM: dosage
Item
Cyclophosphamide 1000 mg/mˆ2/ED
float
C0010583 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
CPM: date of administration
Item
Cyclophosphamide Date of administration
date
C0010583 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
ARA-C: administration form
Item
ARA-C administration form i.v.
boolean
C0010711 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
ARA-C: dosage
Item
ARA-C dosage 75 mg/mˆ2/ED
float
C0010711 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
ARA-C: date of administration
Item
ARA-C Date of administration
date
C0010711 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
TG: administration form
Item
Thioguanine administration form p.o. (14d)
boolean
C0039902 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
TG: dosage
Item
Thioguanine dosage 60 mg/mˆ2/d
float
C0039902 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
TG: start date
Item
Thioguanine Start date of therapy
date
C0039902 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
TG: end date
Item
Thioguanine End date of therapy
date
C0806020 (UMLS CUI [1])
MTX: administration form
Item
MTX administration form i.th
boolean
C0025677 (UMLS CUI [1,1])
C0677897 (UMLS CUI [1,2])
MTX: dosage
Item
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
float
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
MTX: date of administration
Item
MTX Date of administration (while MTX infusion)
date
C0025677 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
Item Group
Hospitalization
C0019993 (UMLS CUI-1)
Hospital nights
Item
If member of randomization group R2, specify: Number of Nights in Hospital (Day 36 until start of maintenance treatment)
float
C0420496 (UMLS CUI [1])
Item Group
Identification and Signature
C0205396 (UMLS CUI-1)
C1519316 (UMLS CUI-3)
Chemotherapy creator: signature
Item
Date and signature of the doctor who calculated and created chemotherapy regimen
text
C0392920 (UMLS CUI [1,1])
C1707531 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Chemotherapy administration: signature
Item
Date and signature of the person who administered chemotherapy
text
C0392920 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial